CIM LLC’s Cocrystal Pharma COCP Stock Holding History

CIM LLC’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-917	Closed	-$10K	–	151
2021 Q3	$10K	Hold	917	–	–	﹤0.01%	161
2021 Q2	$12K	Hold	917	–	–	﹤0.01%	161
2021 Q1	$13K	Buy	+917	New	+$18.6K	﹤0.01%	159

Other funds holding COCP

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

CIM LLC's COCP Position: Q4 2021 in Review

CIM LLC sold out of Cocrystal Pharma (COCP) in Q4 2021, closing a stake of 917 shares — an estimated $10K sold.

CIM LLC first reported a position in COCP in Q1 2021 and held it in 3 quarters. The position peaked at $13K in Q1 2021. 35 funds tracked by Wall St. Rank hold COCP as of Q4 2021.

CIM LLC reported no remaining Cocrystal Pharma position as of Q4 2021 after selling out during the quarter.
CIM LLC sold 917 Cocrystal Pharma shares in Q4 2021, an estimated $10K.
CIM LLC first reported a position in Cocrystal Pharma in Q1 2021 and held it in 3 quarters.
CIM LLC's Cocrystal Pharma position peaked at $13K in Q1 2021.
35 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2021.

Based on CIM LLC's 13F filing for Q4 2021, filed 26 Jan 2022.